Orchestra BioMed Holdings, Inc. Accumulated Other Comprehensive Income
Orchestra BioMed Holdings, Inc. (OBIO) had Accumulated Other Comprehensive Income of -$81.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2026-08-10
- 2026-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$81.00K.
- 2026-03-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$40.00K.
- 2025-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $60.00K.
- 2025-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax $45.00K.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax |
|---|---|
| 2026-06-30 | -$81.00K 10-Q · filed 2026-08-10 |
| 2026-03-31 | -$40.00K 10-Q · filed 2026-05-12 |
| 2025-12-31 | $60.00K 10-Q · filed 2026-08-10 |
| 2025-09-30 | $45.00K 10-Q · filed 2025-11-10 |
| 2025-06-30 | $16.00K 10-Q · filed 2025-08-12 |
| 2025-03-31 | $37.00K 10-Q · filed 2025-05-12 |
| 2024-12-31 | $52.00K 10-K · filed 2026-03-12 |
| 2024-09-30 | $98.00K 10-Q · filed 2024-11-12 |
| 2024-06-30 | -$23.00K 10-Q · filed 2024-08-12 |
| 2024-03-31 | -$8.00K 10-Q · filed 2024-05-13 |
| 2023-12-31 | -$10.00K 10-K · filed 2025-03-31 |
| 2023-09-30 | -$77.00K 10-Q · filed 2023-11-13 |
| 2023-06-30 | -$96.00K 10-Q · filed 2023-08-10 |
| 2023-03-31 | -$35.00K 10-Q · filed 2023-05-12 |
| 2022-12-31 | -$8.00K 10-K · filed 2024-03-27 |
| 2020-12-31 | -$3.56M 10-K/A · filed 2022-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |